https://annoviant.com/2021/10/annoviant-awarded-1-85m-sbir-phase-ii-grant-from-the-national-institutes-of-health/2022-05-19T14:28:45+00:00https://annoviant.com/2022/10/txguard-a-platform-technology-for-cardiovascular-devices-in-the-pediatric-patient/2022-10-18T14:43:56+00:00https://annoviant.com/2022/11/kevin-maher-md-joins-the-annoviant-team-as-scientific-advisor/2022-12-05T15:53:14+00:00https://annoviant.com/2022/12/the-annoviant-team-welcomes-bob-storey-as-business-advisor/2022-12-05T15:53:09+00:00https://annoviant.com/2022/12/17-startups-join-atl-accelerator-designed-for-life-science-medical-device-founders/2022-12-12T19:20:16+00:00https://annoviant.com/2023/02/the-annoviant-team-welcomes-gregg-tobin-as-business-advisor/2023-02-21T02:08:46+00:00https://annoviant.com/2023/04/alpharetta-based-annoviant-is-a-medical-device-startup-that-truly-grows-with-patients/2023-04-25T16:16:13+00:00https://annoviant.com/2024/04/annoviant-awarded-2-99-million-nih-grant-to-advance-txguard-pulmonary-valved-conduit-for-pediatric-heart-disease/2024-04-17T14:40:32+00:00https://annoviant.com/2024/08/alpharetta-startups-technology-could-revolutionize-cardiac-surgeries/2024-08-06T14:27:40+00:00